Aryan Henry E, Meltzer Hal S, Park Min S, Bennett Rebecca L, Jandial Rahul, Levy Michael L
Division of Neurosurgery, Children's Hospital, San Diego, CA, USA.
Childs Nerv Syst. 2005 Jan;21(1):56-61. doi: 10.1007/s00381-004-1052-x. Epub 2004 Oct 12.
Infection is a major complication of cerebrospinal fluid (CSF) shunting procedures. Recently, rifampin-impregnated and clindamycin-impregnated silicone catheters have been developed in an attempt to prevent and/or reduce the incidence of shunt infections. In vitro and in vivo animal studies have shown their efficacy in reducing bacterial colonization of catheters. However, these shunts are yet to be evaluated in clinical trials and their safety and efficacy in preventing shunt infections is unknown.
Between April 2002 and April 2003, 31 children (age range 6 months to 17 years, mean 4.5 years) underwent implantation of an antibiotic-impregnated silicone catheter for CSF diversion. All surgeries were performed by a single neurosurgeon (HSM) at a single medical center. The Codman Hakim Bactiseal silicone catheter was used in all children. Thirty-two catheters were implanted in 31 children. All children have been followed since surgery (for an average of 19 months). For comparison, the previous 46 standard implanted shunts over a similar period of time were reviewed (average follow-up 31 months).
Of the 32 implanted catheters, 11 involved placement of a new complete shunt system, 8 were distal revisions, and 13 were proximal/ventricular revisions. There were fewer early and late complications than in the standard shunt group (12.5 and 18.8% vs. 23.9 and 34.8%). There was no local reaction from implantation of the catheters. One child contaminated his distal catheter by disrupting his abdominal incision. None of the other patients have developed any evidence of shunt infection to date.
Rifampin-impregnated and clindamycin-impregnated silicone catheters appear to be safe and well tolerated in children. Preliminary results suggest a low incidence of shunt infection. Longer follow-up and a larger number of patients are needed to more accurately assess the efficacy of these catheters compared with traditional silicone catheters.
感染是脑脊液(CSF)分流手术的主要并发症。最近,已研发出含利福平的和含克林霉素的硅胶导管,试图预防和/或降低分流感染的发生率。体外和体内动物研究已显示出它们在减少导管细菌定植方面的功效。然而,这些分流装置尚未在临床试验中进行评估,其预防分流感染的安全性和有效性尚不清楚。
在2002年4月至2003年4月期间,31名儿童(年龄范围6个月至17岁,平均4.5岁)接受了植入抗生素浸渍硅胶导管进行脑脊液分流术。所有手术均由单一医疗中心的一名神经外科医生(HSM)进行。所有儿童均使用Codman Hakim Bactiseal硅胶导管。在31名儿童中植入了32根导管。自手术以来所有儿童均得到随访(平均19个月)。作为对照,回顾了同期之前植入的46根标准分流管(平均随访31个月)。
在32根植入的导管中,11根用于植入新的完整分流系统,8根用于远端修复,13根用于近端/脑室修复。与标准分流组相比,早期和晚期并发症更少(分别为12.5%和18.8%,而标准分流组为23.9%和34.8%)。导管植入后未出现局部反应。一名儿童因腹部切口裂开污染了其远端导管。迄今为止,其他患者均未出现任何分流感染的迹象。
含利福平的和含克林霉素的硅胶导管在儿童中似乎是安全且耐受性良好的。初步结果表明分流感染发生率较低。与传统硅胶导管相比,需要更长时间的随访和更多患者来更准确地评估这些导管的疗效。